Skip to main content

Day One Biopharmaceuticals Inc. Common Stock (DAWN)

About The Company

DAWN Stock Market Logo

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The lead product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

IPO Year Sector Industry
2021 Health Care Biotechnology: Pharmaceutical Preparations

Day One Biopharmaceuticals Inc. (DAWN) Latest News

Company Contact & Address (DAWN)

Corporate Headquarters Phone Website
United States
+1 650 484-0899 Official DAWN Website

DAWN Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ DAWN

Jobs & Employment at Day One Biopharmaceuticals Inc.

LinkedIn Company Page
Official Career & Employment Page See LinkedIn page for the jobs, employment & careers details.

Related & Similar Stock Symbols

ADOCR Stock Market Price & News


Edoc Acquisition Corp. Right

XNET Stock Market Price & News


Xunlei Limited American Depositary Shares

DIBS Stock Market Price & News

DIBS Inc. Common Stock